FireCon™ CPE Chlorinated Polyethylene Jacketing Materials FireCon™ CPE formulations are flame-retardant jacketing materials designed for use in low-voltage power and control cables which are routinely exposed to harsh chemicals and low temperatures. Cable constructions using FireCon CPE formulations are suitable for the following UL Standards: UL 13 - Power-Limited Circuit Cables UL 44 - Thermoset-Insulated Wire and Cable UL 62 - Flexible Cords and Cables UL 1277 - Electrical Power and Control Tray Cables with Optional Optical-Fiber Members UL 2250 - Instrumentation Tray Cable KEY CHARACTERISTICS • Retains flexibility at temperatures below 0°C • Resistant to acids, alkalis, oils, fuels and chemical solvents • Excellent balance of physical properties • Suitable for VW1 and tray cable rated applications • Available in UV resistant grades • Available in custom colors MARKETS AND APPLICATIONS • Oil, gas and petroleum applications • Tray cable • Industrial cable • Low-voltage power cables • Medium-voltage power cables • Control cables • VW1 applications PRODUCT BULLETIN To learn more about FireCon CPE jacketing solutions, contact Avient at 1.844.4AVIENT www.avient.com FIRECON™ CPE 30-33 RoHS CPE 37-36 RoHS CPE 37-31 RoHS CPE 37-31 RoHS Natural Specific Gravity 1.31 1.38 1.39 1.39 MFI (190°C, 21.6 Kg) 15 22.4 34.3 34 Durometer Hardness 39D 31D 34D 34D Tensile Strength, PSI 1,499 2,200 2,096 1,800 Tensile Elongation (%) 350 300 325 300 UL Temperature Rating °C 90 90 90 90 LOI (% Oxygen) 30 37 37 37 Brittleness Temperature °C -33 -36 -31 -31 TECHNICAL PROPERTIES Copyright © 2020, Avient Corporation.

What is hiding power? Hiding power describes whether you can see the light source (for example, an LED) through the lens, or not. Hiding power?

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the final amount of charges resulting from the planned North American asset realignment and the Company's ability to realize anticipated savings and operational benefits from the asset realignment; our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the inability to achieve expected results from our acquisition activities; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. Below is a reconciliation of these non-GAAP financial measures to their most directly comparable measures calculated and presented in accordance with U.S. Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with GAAP.

Mevopur™ Healthcare Functional Additives Chemical Foaming Agents (CFA) for Medical Devices and Pharmaceutical Packaging As the need to integrate sustainability in the design of healthcare products is growing, manufacturers of medical devices and pharmaceutical packaging are looking for materials with a more environmentally-friendly profile. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture. Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery.

OUR CODE OF INTEGRITY IN OUR CORPORATE SOCIAL CODE OF CONDUCT | 16 Social Media and Social Networking Avient recognizes that social media/networks may be valuable professionally. When using social media/networks, you must exercise sound judgment and minimize actual or potential security and legal risks. In these settings, Avient permits the consumption of alcohol, in moderation, provided that the safety of the public and the participants is assured.

Below is a reconciliation of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with GAAP. Below is a reconciliation of Adjusted EBITDA to the most directly comparable financial measure calculated and presented in accordance with GAAP. Below is a reconciliation of Net Debt to the most directly comparable financial measures calculated and presented in accordance with GAAP.

MEDICAL DEVICE DISINFECTION—HOW TO PREVENT CRACKING AND CRAZING Understanding polymer performance is key to minimizing disinfectant-related failures DISINFECTANT-RELATED DAMAGE ON POLYMER HOUSINGS Strong chemicals used to reduce hospital- acquired infections can damage equipment and result in material failures, such as: • Stress cracking • Crazing • Discoloration CHEMICAL RESISTANCE REQUIREMENTS VARY BY ENVIRONMENT • Patient/exam rooms • Operating and radiology rooms • Reception areas • Home (patient equipment & devices) Healthcare devices must perform flawlessly in a myriad of challenging environments and engineers must be certain their devices can withstand increasingly potent disinfectants, which have begun to outstrip the performance of traditional polymers. Additionally, the wide variability of environments that medical devices might see, which can range from home to hospital, mean devices must be able to withstand varying disinfectant strengths, exposure levels and frequencies. Whether you are designing for a medical device housing or a surgical device in the operating room, we offer solutions to meet a wide variety of performance specifications and application needs.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Color can be combined with additives to enhance performance and protection REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Device Master File • Food contact established with FDA/EU* NOMINAL OUTSIDE DIAMETER OF NEEDLE (MM) COLOR DESCRIPTION RAL PANTONE TRANSPARENT PRODUCT CODE OPAQUE PRODUCT CODE 0.4 Medium Grey 7035 423 C PP7M665125 PP7M665127 0.45 Brown 8017 7588 C PP8M665294 PP8M665296 0.5 Orange 2003 173 C PP2M665298 PP2M665300 0.55 Medium Purple 4005 7676 C PP4M665290 PP4M665292 0.6 Deep Blue 5010 288 C PP5M665894 PP5M665896 0.7 Black 9005 Black C PP9M664950 PP9M664952 0.8 Deep Green 6001 7483 C PP6M665687 PP6M665689 0.9 Yellow 1021 115 C PP1M665211 PP1M665213 1.1 Cream 1015 7401 C PP0M665290 PP0M665292 1.2 Pink 3015 502 C PE3M665725 PP3M665727 Healthcare use limitations apply—see below. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture. Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery.

Avient’s portfolio of healthcare additives helps enhance the performance and functionality of plastics used in drug delivery devices, in vitro diagnostic devices, and pharmaceutical packaging. Performance Fiber Conversion Calculator Designed to help you overcome challenges for healthcare devices and applications

Use this simple calculation: Specific Gravity X Price Per Pound = Pound/Volume Cost In Handbook of Polymer Applications in Medicine and Medical Devices,¹ Laurence W. ¹http://store.elsevier.com/Handbook-of-Polymer-Applications-in-Medicine-and-Medical-Devices/isbn-9780323221696/